Fibromyalgia Treatment with Chiropractic

If you suffer from fibromyalgia, you are not alone, as Dr. Ulvin sees many patients with this particular problem in our Stacy chiropractic practice. As a matter of fact, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the United States have fibromyalgia problems. Luckily, chiropractic adjustments is one treatment option that can provide positive results.

Research Proves Chiropractic Care Helps Fibromyalgia Issues

In a paper published in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression symptoms or anxiety they felt. Then they were split into two groups with one group receiving a multi-modal treatment plan for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The individuals who received chiropractic adjustments in conjunction with the multi-disciplinary therapy program reported greater benefits in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study participants who received multi-modal treatment without chiropractic adjustments. Additionally, those positive outcomes were long-lasting as the individuals reported continued improvement one full year later.

Fibromyalgia discomfort can greatly diminish your quality of life, both psychologically and physically. If you're suffering from fibromyalgia, we might be able to help.

You don't have to suffer! To learn what Dr. Ulvin can do for your fibromyalgia discomfort, call our Stacy chiropractic office today.

Resources

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.